News

Approval was based on positive data from the Phase III MARCH study across a range of genetic progressive familial intrahepatic cholestasis types.

This financial toxicity is quite prominent, but what can be done to remedy treatment costs?

Under the group purchasing agreement, the serialization business will be the sole provider of DSCSA services for Premier’s 4,300-plus hospital and health system network.

The latest news for pharma industry insiders.

Steven H. Collis, who currently holds the position, will transition to executive chair of the board.

The Asia-Pacific location is expected to provide serialization solutions for counterfeit medication entering the pharma supply chain.

The latest news for pharma industry insiders.

A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.

A qualitative study explores how these drugs are impacting these patients’ lives, while digging deeper into the possibility of deprescribing, with insight from primary care physicians.

A USC study discovers that an increasing share of both generic and brand-name meds are being excluded from approval.

The latest news for pharma industry insiders.

With out-of-pocket healthcare costs resulting in financial issues for patients, a cross-sectional study closely examines whether they are linked to more premature deaths.

A proposed Senate bill is intended to protect citizens’ private health and genetic information.

The latest news for pharma industry insiders.

The contributions consist of multiple investments that aim to boost pandemic preparedness and overall public health protection.

The CDMO’s multi-million-dollar expansion project features commercial manufacturing suites and peptide manufacturing plants.

The latest news for pharma industry insiders.

Navigating the complex landscape of healthcare coverage can be an intimidating task, especially for patients with rare diseases for which treatments often come with a high price tag.

The latest news for pharma industry insiders.

The CDC urges healthcare providers to preserve their current supply.

The pTau217 antibody helps pinpoint pathological changes related to the disease.

The latest news for pharma industry insiders.

Momentum from the previous two years will propel the sector into the rest of 2024, says AM Best analysis.

The purchase boosts the parties’ sterile liquid manufacturing capabilities.

The latest news for pharma industry insiders.

A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics.

With its aims to protect healthcare consumers against the dangers of counterfeit, contaminated, stolen or otherwise harmful drugs, the DSCSA represents a significant step forward in securing the pharmaceutical supply chain.

The offering reportedly helps avoid product quarantine.